Pillstats
Rx only · Capsule, Gelatin Coated · Oral

Dextromethorphan Hydrobromide And Quinidine Sulfate

Brands: Nuedexta · Dextromethorphan Hydrobromide + Quinidine Sulfate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9068
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$7.66$15.32$22.98$30.65Dec 2025May 2026Jul 2026
$26.600
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.4K6.7K10K13K2025 Q12025 Q22025 Q32025 Q42026 Q1
10K
Rx · 2026 Q1
519K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Otsuka America Pharmaceutical, Inc.unknown2SUPPLYING
Avanir Pharmaceuticals, Inc.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules Rx only NDC 64597-301-60 Manufac…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC